Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Sirius Huang -- 3380 2022-09-28 01:36:39

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Diabetes Mellitus Type 2. Encyclopedia. Available online: https://encyclopedia.pub/entry/27876 (accessed on 22 September 2026).
HandWiki. Diabetes Mellitus Type 2. Encyclopedia. Available at: https://encyclopedia.pub/entry/27876. Accessed September 22, 2026.
HandWiki. "Diabetes Mellitus Type 2" Encyclopedia, https://encyclopedia.pub/entry/27876 (accessed September 22, 2026).
HandWiki. (2022, September 28). Diabetes Mellitus Type 2. In Encyclopedia. https://encyclopedia.pub/entry/27876
HandWiki. "Diabetes Mellitus Type 2." Encyclopedia. Web. 28 September, 2022.
Diabetes Mellitus Type 2
Edit
The content is sourced from: https://handwiki.org/wiki/Medicine:Diabetes_mellitus_type_2

Diabetes mellitus type 2 (also known as type 2 diabetes) is a long-term metabolic disorder that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, and unexplained weight loss. Symptoms may also include increased hunger, feeling tired, and sores that do not heal. Often symptoms come on slowly. Long-term complications from high blood sugar include heart disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon. Type 2 diabetes primarily occurs as a result of obesity and lack of exercise. Some people are more genetically at risk than others. Type 2 diabetes makes up about 90% of cases of diabetes, with the other 10% due primarily to diabetes mellitus type 1 and gestational diabetes. In diabetes mellitus type 1 there is a lower total level of insulin to control blood glucose, due to an autoimmune induced loss of insulin-producing beta cells in the pancreas. Diagnosis of diabetes is by blood tests such as fasting plasma glucose, oral glucose tolerance test, or glycated hemoglobin (A1C). Type 2 diabetes is partly preventable by staying a normal weight, exercising regularly, and eating properly. Treatment involves exercise and dietary changes. If blood sugar levels are not adequately lowered, the medication metformin is typically recommended. Many people may eventually also require insulin injections. In those on insulin, routinely checking blood sugar levels is advised; however, this may not be needed in those taking pills. Bariatric surgery often improves diabetes in those who are obese. Rates of type 2 diabetes have increased markedly since 1960 in parallel with obesity. As of 2015 there were approximately 392 million people diagnosed with the disease compared to around 30 million in 1985. Typically it begins in middle or older age, although rates of type 2 diabetes are increasing in young people. Type 2 diabetes is associated with a ten-year-shorter life expectancy. Diabetes was one of the first diseases described. The importance of insulin in the disease was determined in the 1920s.

oral glucose tolerance diabetes mellitus type 1 glycated hemoglobin

References

  1. Vijan, S (2010-03-02). "Type 2 diabetes". Annals of Internal Medicine 152 (5): ITC31–ITC15; quiz ITC316. doi:10.7326/0003-4819-152-5-201003020-01003. PMID 20194231.  https://dx.doi.org/10.7326%2F0003-4819-152-5-201003020-01003
  2. Gardner, David G.; Shoback, Dolores, eds (2011). "Chapter 17: Pancreatic hormones & diabetes mellitus". Greenspan's basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. ISBN 0-07-162243-8. OCLC 613429053.  http://www.worldcat.org/oclc/613429053
  3. Melmed, Shlomo; Polonsky, Kenneth S.; Larsen, P. Reed et al., eds. Williams textbook of endocrinology. (12th ed.). Philadelphia: Elsevier/Saunders. pp. 1371–1435. ISBN 978-1-4377-0324-5. 
  4. "Management of blood glucose in type 2 diabetes mellitus". American Family Physician 79 (1): 29–36. January 2009. PMID 19145963.  http://www.ncbi.nlm.nih.gov/pubmed/19145963
  5. Pasquier, F (October 2010). "Diabetes and cognitive impairment: how to evaluate the cognitive status?". Diabetes & Metabolism 36 Suppl 3: S100–05. doi:10.1016/S1262-3636(10)70475-4. PMID 21211730.  https://dx.doi.org/10.1016%2FS1262-3636%2810%2970475-4
  6. Risérus, U; Willett, WC; Hu, FB (January 2009). "Dietary fats and prevention of type 2 diabetes". Progress in Lipid Research 48 (1): 44–51. doi:10.1016/j.plipres.2008.10.002. PMID 19032965.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2654180
  7. Touma, C; Pannain, S (August 2011). "Does lack of sleep cause diabetes?". Cleveland Clinic Journal of Medicine 78 (8): 549–58. doi:10.3949/ccjm.78a.10165. PMID 21807927.  https://dx.doi.org/10.3949%2Fccjm.78a.10165
  8. Christian, P; Stewart, CP (March 2010). "Maternal micronutrient deficiency, fetal development, and the risk of chronic disease". The Journal of Nutrition 140 (3): 437–45. doi:10.3945/jn.109.116327. PMID 20071652.  https://dx.doi.org/10.3945%2Fjn.109.116327
  9. Pedersen, HK; Gudmundsdottir, V; Nielsen, HB et al. (21 July 2016). "Human gut microbes impact host serum metabolome and insulin sensitivity". Nature 535 (7612): 376–81. doi:10.1038/nature18646. PMID 27409811. Bibcode: 2016Natur.535..376P.  https://dx.doi.org/10.1038%2Fnature18646
  10. Abdullah, A; Peeters, A; de Courten, M; Stoelwinder, J (September 2010). "The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies.". Diabetes Research and Clinical Practice 89 (3): 309–19. doi:10.1016/j.diabres.2010.04.012. PMID 20493574.  https://dx.doi.org/10.1016%2Fj.diabres.2010.04.012
  11. Pan, A; Wang, Y; Talaei, M; Hu, FB; Wu, T (17 September 2015). "Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis". The Lancet Diabetes & Endocrinology 3 (12): 958–67. doi:10.1016/S2213-8587(15)00316-2. PMID 26388413.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4656094
  12. Malik, VS; Popkin, BM; Bray, GA; Després, JP; Hu, FB (2010-03-23). "Sugar Sweetened Beverages, Obesity, Type 2 Diabetes and Cardiovascular Disease risk". Circulation 121 (11): 1356–64. doi:10.1161/CIRCULATIONAHA.109.876185. PMID 20308626.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2862465
  13. Malik, VS; Popkin, BM; Bray, GA; Després, JP; Willett, WC; Hu, FB (November 2010). "Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis". Diabetes Care 33 (11): 2477–83. doi:10.2337/dc10-1079. PMID 20693348.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2963518
  14. Hu, EA; Pan, A; Malik, V; Sun, Q (2012-03-15). "White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review". The BMJ 344: e1454. doi:10.1136/bmj.e1454. PMID 22422870.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3307808
  15. Lee, I-Min; Shiroma, Eric J; Lobelo, Felipe; Puska, Pekka; Blair, Steven N; Katzmarzyk, Peter T (1 July 2012). "Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy". The Lancet 380 (9838): 219–29. doi:10.1016/S0140-6736(12)61031-9. PMID 22818936.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3645500
  16. Lind, L; Lind, PM (Jun 2012). "Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease?". Journal of Internal Medicine 271 (6): 537–53. doi:10.1111/j.1365-2796.2012.02536.x. PMID 22372998.  https://dx.doi.org/10.1111%2Fj.1365-2796.2012.02536.x
  17. Herder, C; Roden, M (June 2011). "Genetics of type 2 diabetes: pathophysiologic and clinical relevance". European Journal of Clinical Investigation 41 (6): 679–92. doi:10.1111/j.1365-2362.2010.02454.x. PMID 21198561.  https://dx.doi.org/10.1111%2Fj.1365-2362.2010.02454.x
  18. "Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young". National Diabetes Information Clearinghouse (NDIC) (National Institute of Diabetes and Digestive and Kidney Diseases, NIH). March 2007. Archived from the original on 2008-07-04. https://web.archive.org/web/20080704103703/http://diabetes.niddk.nih.gov/dm/pubs/mody/. Retrieved 2008-08-04. 
  19. Funnell, Martha M.; Anderson, Robert M. (2008). "Influencing self-management: from compliance to collaboration". in Feinglos, Mark N.; Bethel, M. Angelyn. Type 2 diabetes mellitus: an evidence-based approach to practical management. Contemporary endocrinology. Totowa, NJ: Humana Press. p. 462. ISBN 978-1-58829-794-5. OCLC 261324723. https://books.google.com/books?id=Cn-9BAAAQBAJ&pg=PA455. 
  20. Izzedine, H; Launay-Vacher, V; Deybach, C; Bourry, E; Barrou, B; Deray, G (November 2005). "Drug-induced diabetes mellitus". Expert Opinion on Drug Safety 4 (6): 1097–1109. doi:10.1517/14740338.4.6.1097. PMID 16255667.  https://dx.doi.org/10.1517%2F14740338.4.6.1097
  21. Sampson, UK; Linton, MF; Fazio, S (July 2011). "Are statins diabetogenic?". Current Opinion in Cardiology 26 (4): 342–47. doi:10.1097/HCO.0b013e3283470359. PMID 21499090.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3341610
  22. Saad, Farid; Gooren, Louis (March 2009). "The role of testosterone in the metabolic syndrome: a review". The Journal of Steroid Biochemistry and Molecular Biology 114 (1–2): 40–43. doi:10.1016/j.jsbmb.2008.12.022. PMID 19444934.  https://dx.doi.org/10.1016%2Fj.jsbmb.2008.12.022
  23. Farrell, JoAnne B.; Deshmukh, Anjali; Baghaie, Ali A. (2008). "Low testosterone and the association with type 2 diabetes". The Diabetes Educator 34 (5): 799–806. doi:10.1177/0145721708323100. PMID 18832284.  https://dx.doi.org/10.1177%2F0145721708323100
  24. Diabetes mellitus a guide to patient care.. Philadelphia: Lippincott Williams & Wilkins. 2007. p. 15. ISBN 978-1-58255-732-8. https://books.google.com/books?id=fiAclxvKblkC&pg=PA15. 
  25. World Health Organization. "Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus". Archived from the original on 2007-05-29. https://web.archive.org/web/20070529092627/http://www.who.int/diabetes/publications/en/. Retrieved 2007-05-29. 
  26. International Expert, Committee (July 2009). "International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes". Diabetes Care 32 (7): 1327–34. doi:10.2337/dc09-9033. PMID 19502545.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2699715
  27. "Diagnosis and classification of diabetes mellitus". Diabetes Care (American Diabetes Association) 33 Suppl 1 (Supplement_1): S62–69. January 2010. doi:10.2337/dc10-S062. PMID 20042775.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2797383
  28. "Diagnosis and classification of diabetes mellitus". Diabetes Care (American Diabetes Association) 35 Suppl 1 (Suppl 1): S64–71. January 2012. doi:10.2337/dc12-s064. PMID 22187472.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3632174
  29. Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Cotran, Ramzi S.; Robbins, Stanley L. (2005). Robbins and Cotran Pathologic Basis of Disease (7th ed.). Philadelphia, Pa.: Saunders. pp. 1194–95. ISBN 0-7216-0187-1. 
  30. Diabetes mellitus a guide to patient care.. Philadelphia: Lippincott Williams & Wilkins. 2007. p. 201. ISBN 978-1-58255-732-8. https://books.google.com/books?id=fiAclxvKblkC&pg=PA201. 
  31. Vivian, Eva M.; Blackorbay, Brady (2013). "Chapter 13: Endocrine Disorders". in Lee, Mary. Basic Skills in Interpreting Laboratory Data (5th ed.). Bethesda, MD: American Society of Health-System Pharmacists. ISBN 978-1-58528-345-3. OCLC 859778842. https://books.google.com/books?id=5WW1AAAAQBAJ&pg=PT539. 
  32. Valdez R (2009). "Detecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Tool". Journal of Diabetes Science and Technology 3 (4): 722–26. doi:10.1177/193229680900300417. PMID 20144319.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2769984
  33. Selph, S; Dana, T; Blazina, I; Bougatsos, C; Patel, H; Chou, R (22 June 2015). "Screening for Type 2 Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force". Annals of Internal Medicine 162 (11): 765–76. doi:10.7326/M14-2221. PMID 25867111.  https://dx.doi.org/10.7326%2FM14-2221
  34. "Archived: Diabetes Mellitus (Type 2) in Adults: Screening". U.S. Preventive Services Task Force. June 2008. Archived from the original on 2014-02-07. https://web.archive.org/web/20140207214318/http://www.uspreventiveservicestaskforce.org/uspstf/uspsdiab.htm. Retrieved 2014-03-16. 
  35. Siu, AL (27 October 2015). "Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine 163 (11): 861–68. doi:10.7326/M15-2345. PMID 26501513.  https://dx.doi.org/10.7326%2FM15-2345
  36. "Draft Recommendation Statement Screening for Abnormal Glucose and Type 2 Diabetes Mellitus". http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementDraft/screening-for-abnormal-glucose-and-type-2-diabetes-mellitus. Retrieved 7 October 2014. 
  37. "Standards of Medical Care in Diabetes – 2015: Summary of Revisions". Diabetes Care 54 (38): S4. 2015. doi:10.2337/dc15-S003. PMID 25537706.  https://dx.doi.org/10.2337%2Fdc15-S003
  38. "Lifestyle interventions reduced the long-term risk of diabetes in adults with impaired glucose tolerance". Evidence-Based Medicine 13 (6): 173. December 2008. doi:10.1136/ebm.13.6.173. PMID 19043031.  https://dx.doi.org/10.1136%2Febm.13.6.173
  39. Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roqué I Figuls M, Richter B, Mauricio D (2008). Mauricio, Didac. ed. "Exercise or exercise and diet for preventing type 2 diabetes mellitus". Cochrane Database of Systematic Reviews (3): CD003054. doi:10.1002/14651858.CD003054.pub3. PMID 18646086.  https://dx.doi.org/10.1002%2F14651858.CD003054.pub3
  40. Schellenberg, ES.; Dryden, DM.; Vandermeer, B.; Ha, C.; Korownyk, C. (October 2013). "Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes: A Systematic Review and Meta-analysis". Annals of Internal Medicine 159 (8): 543–51. doi:10.7326/0003-4819-159-8-201310150-00007. PMID 24126648.  https://dx.doi.org/10.7326%2F0003-4819-159-8-201310150-00007
  41. O'Gorman, DJ; Krook, A (September 2011). "Exercise and the treatment of diabetes and obesity". Medical Clinics of North America 95 (5): 953–69. doi:10.1016/j.mcna.2011.06.007. PMID 21855702.  https://dx.doi.org/10.1016%2Fj.mcna.2011.06.007
  42. Kyu, Hmwe H.; Bachman, Victoria F.; Alexander, Lily T.; Mumford, John Everett; Afshin, Ashkan; Estep, Kara; Veerman, J. Lennert; Delwiche, Kristen et al. (9 August 2016). "Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013". The BMJ 354: i3857. doi:10.1136/bmj.i3857. PMID 27510511.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4979358
  43. Nield L, Summerbell CD, Hooper L, Whittaker V, Moore H (2008). Nield, Lucie. ed. "Dietary advice for the prevention of type 2 diabetes mellitus in adults". Cochrane Database of Systematic Reviews (3): CD005102. doi:10.1002/14651858.CD005102.pub2. PMID 18646120.  https://dx.doi.org/10.1002%2F14651858.CD005102.pub2
  44. Carter, P; Gray, LJ; Troughton, J; Khunti, K; Davies, MJ (2010-08-18). "Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis". The BMJ 341: c4229. doi:10.1136/bmj.c4229. PMID 20724400.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2924474
  45. "Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose" (PDF). Evidence Report/Technology Assessment (Summary) (128): 1–11. August 2005. PMID 16194123. PMC 4780988. Archived from the original on 2008-09-10. https://web.archive.org/web/20080910035155/http://www.ahrq.gov/downloads/pub/evidence/pdf/impglucose/impglucose.pdf. 
  46. Haw, JS; Galaviz, KI; Straus, AN; Kowalski, AJ; Magee, MJ; Weber, MB; Wei, J; Narayan, KMV et al. (6 November 2017). "Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials". JAMA Internal Medicine 177 (12): 1808–17. doi:10.1001/jamainternmed.2017.6040. PMID 29114778.  https://dx.doi.org/10.1001%2Fjamainternmed.2017.6040
  47. Seida, Jennifer C.; Mitri, Joanna; Colmers, Isabelle N.; Majumdar, Sumit R.; Davidson, Mayer B.; Edwards, Alun L.; Hanley, David A.; Pittas, Anastassios G. et al. (Oct 2014). "Effect of Vitamin D3 Supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematic Review and Meta-Analysis". The Journal of Clinical Endocrinology & Metabolism 99 (10): 3551–60. doi:10.1210/jc.2014-2136. PMID 25062463.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4483466
  48. "Type 2 diabetes: The management of type 2 diabetes". May 2009. Archived from the original on 2015-05-22. https://web.archive.org/web/20150522055955/http://www.nice.org.uk/guidance/cg87/chapter/1-recommendations#self-monitoring-of-plasma-glucose. 
  49. Farmer, AJ; Perera, R; Ward, A; Heneghan, C; Oke, J; Barnett, AH; Davidson, MB; Guerci, B et al. (27 February 2012). "Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes". The BMJ 344: e486. doi:10.1136/bmj.e486. PMID 22371867.  https://dx.doi.org/10.1136%2Fbmj.e486
  50. Emdin, CA; Rahimi, K; Neal, B; Callender, T; Perkovic, V; Patel, A (10 February 2015). "Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis". JAMA: the Journal of the American Medical Association 313 (6): 603–15. doi:10.1001/jama.2014.18574. PMID 25668264.  https://dx.doi.org/10.1001%2Fjama.2014.18574
  51. McBrien, K; Rabi, DM; Campbell, N; Barnieh, L; Clement, F; Hemmelgarn, BR; Tonelli, M; Leiter, LA et al. (6 August 2012). "Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis". Archives of Internal Medicine 172 (17): 1–8. doi:10.1001/archinternmed.2012.3147. PMID 22868819.  https://dx.doi.org/10.1001%2Farchinternmed.2012.3147
  52. Boussageon, R; Bejan-Angoulvant, T; Saadatian-Elahi, M; Lafont, S; Bergeonneau, C; Kassaï, B; Erpeldinger, S; Wright, JM et al. (2011-07-26). "Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials". The BMJ 343: d4169. doi:10.1136/bmj.d4169. PMID 21791495.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3144314
  53. Webster, MW (July 2011). "Clinical practice and implications of recent diabetes trials". Current Opinion in Cardiology 26 (4): 288–93. doi:10.1097/HCO.0b013e328347b139. PMID 21577100.  https://dx.doi.org/10.1097%2FHCO.0b013e328347b139
  54. Inzucchi, SE; Bergenstal, RM; Buse, JB; Diamant, M; Ferrannini, E; Nauck, M; Peters, AL; Tsapas, A et al. (March 2015). "Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.". Diabetologia 58 (3): 429–42. doi:10.1007/s00125-014-3460-0. PMID 25583541.  https://dx.doi.org/10.1007%2Fs00125-014-3460-0
  55. Qaseem, Amir; Wilt, Timothy J.; Kansagara, Devan; Horwitch, Carrie; Barry, Michael J.; Forciea, Mary Ann (6 March 2018). "Hemoglobin A Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians". Annals of Internal Medicine. doi:10.7326/M17-0939.  https://dx.doi.org/10.7326%2FM17-0939
  56. Makam, AN; Nguyen, OK (10 January 2017). "An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.". Circulation 135 (2): 180–95. doi:10.1161/CIRCULATIONAHA.116.022622. PMID 28069712.  https://dx.doi.org/10.1161%2FCIRCULATIONAHA.116.022622
  57. Simpson, Terry C.; Weldon, Jo C.; Worthington, Helen V.; Needleman, Ian; Wild, Sarah H.; Moles, David R.; Stevenson, Brian; Furness, Susan et al. (2015-11-06). "Treatment of periodontal disease for glycaemic control in people with diabetes mellitus". Cochrane Database of Systematic Reviews (11): CD004714. doi:10.1002/14651858.CD004714.pub3. ISSN 1469-493X. PMID 26545069.  https://dx.doi.org/10.1002%2F14651858.CD004714.pub3
  58. Smith, AD; Crippa, A; Woodcock, J; Brage, S (December 2016). "Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies.". Diabetologia 59 (12): 2527–45. doi:10.1007/s00125-016-4079-0. PMID 27747395.  https://dx.doi.org/10.1007%2Fs00125-016-4079-0
  59. Thomas, D. E.; Elliott, E. J.; Naughton, G. A. (2006-07-19). "Exercise for type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews (3): CD002968. doi:10.1002/14651858.CD002968.pub2. ISSN 1469-493X. PMID 16855995.  https://dx.doi.org/10.1002%2F14651858.CD002968.pub2
  60. "Exercise for the management of type 2 diabetes: a review of the evidence". Acta Diabetologica 47 (1): 15–22. March 2010. doi:10.1007/s00592-009-0126-3. PMID 19495557. https://link.springer.com/content/pdf/10.1007%2Fs00592-009-0126-3.pdf. 
  61. "Nutritional strategies in type 2 diabetes mellitus". Mount Sinai Journal of Medicine 76 (3): 257–68. June 2009. doi:10.1002/msj.20118. PMID 19421969.  https://dx.doi.org/10.1002%2Fmsj.20118
  62. Thomas D, Elliott EJ (2009). Thomas, Diana. ed. "Low glycaemic index, or low glycaemic load, diets for diabetes mellitus". Cochrane Database of Systematic Reviews (1): CD006296. doi:10.1002/14651858.CD006296.pub2. PMID 19160276.  https://dx.doi.org/10.1002%2F14651858.CD006296.pub2
  63. Feinman, RD; Pogozelski, WK; Astrup, A; Bernstein, RK; Fine, EJ; Westman, EC; Accurso, A; Frassetto, L et al. (January 2015). "Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base.". Nutrition (Burbank, Los Angeles County, Calif.) 31 (1): 1–13. doi:10.1016/j.nut.2014.06.011. PMID 25287761.  https://dx.doi.org/10.1016%2Fj.nut.2014.06.011
  64. Clifton, P (15 October 2017). "Assessing the evidence for weight loss strategies in people with and without type 2 diabetes.". World Journal of Diabetes 8 (10): 440–454. doi:10.4239/wjd.v8.i10.440. PMID 29085571.  https://dx.doi.org/10.4239%2Fwjd.v8.i10.440
  65. "The health advantage of a vegan diet: exploring the gut microbiota connection". Nutrients 6 (11): 4822–38. 2014. doi:10.3390/nu6114822. PMID 25365383.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4245565
  66. Leach, Matthew J.; Kumar, Saravana (2012-09-12). "Cinnamon for diabetes mellitus". Cochrane Database of Systematic Reviews (9): CD007170. doi:10.1002/14651858.CD007170.pub2. ISSN 1469-493X. PMID 22972104.  https://dx.doi.org/10.1002%2F14651858.CD007170.pub2
  67. Attridge, Madeleine; Creamer, John; Ramsden, Michael; Cannings-John, Rebecca; Hawthorne, Kamila (2014-09-04). "Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus". Cochrane Database of Systematic Reviews (9): CD006424. doi:10.1002/14651858.CD006424.pub3. ISSN 1469-493X. PMID 25188210.  https://dx.doi.org/10.1002%2F14651858.CD006424.pub3
  68. Maruthur, NM; Tseng, E; Hutfless, S; Wilson, LM; Suarez-Cuervo, C; Berger, Z; Chu, Y; Iyoha, E et al. (19 April 2016). "Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis". Annals of Internal Medicine 164 (11): 740–51. doi:10.7326/M15-2650. PMID 27088241.  https://dx.doi.org/10.7326%2FM15-2650
  69. Palmer, Suetonia C.; Mavridis, Dimitris; Nicolucci, Antonio; Johnson, David W.; Tonelli, Marcello; Craig, Jonathan C.; Maggo, Jasjot; Gray, Vanessa et al. (19 July 2016). "Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes". JAMA: the Journal of the American Medical Association 316 (3): 313–24. doi:10.1001/jama.2016.9400. PMID 27434443.  https://dx.doi.org/10.1001%2Fjama.2016.9400
  70. Boussageon, R; Supper, I; Bejan-Angoulvant, T; Kellou, N; Cucherat, M; Boissel, JP; Kassai, B; Moreau, A et al. (2012). Groop, Leif. ed. "Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials". PLOS Medicine 9 (4): e1001204. doi:10.1371/journal.pmed.1001204. PMID 22509138.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3323508
  71. Zheng, Sean L.; Roddick, Alistair J.; Aghar-Jaffar, Rochan; Shun-Shin, Matthew J.; Francis, Darrel; Oliver, Nick; Meeran, Karim (17 April 2018). "Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes". JAMA 319 (15): 1580. doi:10.1001/jama.2018.3024.  https://dx.doi.org/10.1001%2Fjama.2018.3024
  72. Richter, B; Bandeira-Echtler, E; Bergerhoff, K; Clar, C; Ebrahim, SH (18 July 2007). Richter, Bernd. ed. "Rosiglitazone for type 2 diabetes mellitus". Cochrane Database of Systematic Reviews (3): CD006063. doi:10.1002/14651858.CD006063.pub2. PMID 17636824.  https://dx.doi.org/10.1002%2F14651858.CD006063.pub2
  73. Chen, X; Yang, L; Zhai, SD (December 2012). "Risk of cardiovascular disease and all-cause mortality among diabetic patients prescribed rosiglitazone or pioglitazone: a meta-analysis of retrospective cohort studies". Chinese Medical Journal 125 (23): 4301–06. PMID 23217404.  http://www.ncbi.nlm.nih.gov/pubmed/23217404
  74. Lv, J; Perkovic, V; Foote, CV; Craig, ME; Craig, JC; Strippoli, GF (12 December 2012). Strippoli, Giovanni FM. ed. "Antihypertensive agents for preventing diabetic kidney disease". Cochrane Database of Systematic Reviews 12: CD004136. doi:10.1002/14651858.CD004136.pub3. PMID 23235603.  https://dx.doi.org/10.1002%2F14651858.CD004136.pub3
  75. Cheng, J; Zhang, W; Zhang, X; Han, F; Li, X; He, X; Li, Q; Chen, J (May 2014). "Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.". JAMA Internal Medicine 174 (5): 773–85. doi:10.1001/jamainternmed.2014.348. PMID 24687000.  https://dx.doi.org/10.1001%2Fjamainternmed.2014.348
  76. Brunström, Mattias; Carlberg, Bo (24 February 2016). "Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses". The BMJ 352: i717. doi:10.1136/bmj.i717. PMID 26920333.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4770818
  77. Swinnen, SG.; Simon, AC.; Holleman, F.; Hoekstra, JB.; Devries, JH. (2011). Simon, Airin CR. ed. "Insulin detemir versus insulin glargine for type 2 diabetes mellitus". Cochrane Database of Systematic Reviews (7): CD006383. doi:10.1002/14651858.CD006383.pub2. PMID 21735405.  https://dx.doi.org/10.1002%2F14651858.CD006383.pub2
  78. Waugh, N; Cummins, E; Royle, P; Clar, C; Marien, M; Richter, B; Philip, S (July 2010). "Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation". Health Technology Assessment (Winchester, England) 14 (36): 1–248. doi:10.3310/hta14360. PMID 20646668.  https://dx.doi.org/10.3310%2Fhta14360
  79. Mirhosseini, Naghmeh; Vatanparast, Hassanali; Mazidi, Mohsen; Kimball, Samantha M (1 September 2017). "The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis". The Journal of Clinical Endocrinology & Metabolism 102 (9): 3097–3110. doi:10.1210/jc.2017-01024.  https://dx.doi.org/10.1210%2Fjc.2017-01024
  80. Picot, J; Jones, J; Colquitt, JL; Gospodarevskaya, E; Loveman, E; Baxter, L; Clegg, AJ (September 2009). "The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation". Health Technology Assessment (Winchester, England) 13 (41): iii–iv, 1–190, 215–357. doi:10.3310/hta13410. PMID 19726018.  https://dx.doi.org/10.3310%2Fhta13410
  81. Frachetti, KJ; Goldfine, AB (April 2009). "Bariatric surgery for diabetes management". Current Opinion in Endocrinology, Diabetes and Obesity 16 (2): 119–24. doi:10.1097/MED.0b013e32832912e7. PMID 19276974.  https://dx.doi.org/10.1097%2FMED.0b013e32832912e7
  82. Schulman, AP; del Genio, F; Sinha, N; Rubino, F (September–October 2009). ""Metabolic" surgery for treatment of type 2 diabetes mellitus". Endocrine Practice 15 (6): 624–31. doi:10.4158/EP09170.RAR. PMID 19625245.  https://dx.doi.org/10.4158%2FEP09170.RAR
  83. Colucci, RA (January 2011). "Bariatric surgery in patients with type 2 diabetes: a viable option". Postgraduate Medicine 123 (1): 24–33. doi:10.3810/pgm.2011.01.2242. PMID 21293081.  https://dx.doi.org/10.3810%2Fpgm.2011.01.2242
  84. Dixon, JB; le Roux, CW; Rubino, F; Zimmet, P (16 June 2012). "Bariatric surgery for type 2 diabetes". The Lancet 379 (9833): 2300–11. doi:10.1016/S0140-6736(12)60401-2. PMID 22683132.  https://dx.doi.org/10.1016%2FS0140-6736%2812%2960401-2
  85. Rubino, F; Nathan, DM; Eckel, RH; Schauer, PR; Alberti, KG; Zimmet, PZ; Del Prato, S; Ji, L et al. (June 2016). "Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.". Diabetes Care 39 (6): 861–77. doi:10.2337/dc16-0236. PMID 27222544.  https://dx.doi.org/10.2337%2Fdc16-0236
  86. GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.". The Lancet 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMID 27733282.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5055577
  87. "Ethnicity and type 2 diabetes: focus on Asian Indians". Journal of Diabetes and its Complications 15 (6): 320–27. 2001. doi:10.1016/S1056-8727(01)00161-1. PMID 11711326.  https://dx.doi.org/10.1016%2FS1056-8727%2801%2900161-1
  88. Carulli, L; Rondinella, S; Lombardini, S; Canedi, I; Loria, P; Carulli, N (November 2005). "Review article: diabetes, genetics and ethnicity". Alimentary Pharmacology & Therapeutics 22 Suppl 2: 16–19. doi:10.1111/j.1365-2036.2005.02588.x. PMID 16225465.  https://dx.doi.org/10.1111%2Fj.1365-2036.2005.02588.x
  89. Smyth, S; Heron, A (January 2006). "Diabetes and obesity: the twin epidemics". Nature Medicine 12 (1): 75–80. doi:10.1038/nm0106-75. PMID 16397575.  https://dx.doi.org/10.1038%2Fnm0106-75
  90. "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030". Diabetes Care 27 (5): 1047–53. May 2004. doi:10.2337/diacare.27.5.1047. PMID 15111519.  https://dx.doi.org/10.2337%2Fdiacare.27.5.1047
  91. "Diabetes Fact sheet N°312". August 2011. Archived from the original on 26 August 2013. https://web.archive.org/web/20130826174444/http://www.who.int/mediacentre/factsheets/fs312/en/. Retrieved 2012-01-09. 
  92. Leutholtz, Brian C.; Ripoll, Ignacio (2011). "Diabetes". Exercise and disease management (2nd ed.). Boca Raton: CRC Press. p. 25. ISBN 978-1-4398-2759-8. OCLC 725919496.  https://books.google.com/books?id=eAn9-bm_pi8C&pg=PA25
  93. Zajac, Jacek; Shrestha, Anil; Patel, Parini; Poretsky, Leonid (2009). "The Main Events in the History of Diabetes Mellitus". in Poretsky, Leonid. Principles of diabetes mellitus (2nd ed.). New York: Springer. pp. 3–16. ISBN 978-0-387-09840-1. OCLC 663097550.  https://books.google.com/books?id=i0qojvF1SpUC&pg=PA3
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Medicine, General & Internal
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
HandWiki
View Times: 1.7K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 28 Sep 2022
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback